International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1375-1379 , 1 August 2010

Toxicity of Head-and-Neck Radiation Therapy in Human Immunodeficiency Virus–Positive Patients

Presented at the 2007 Multidisciplinary Head and Neck Cancer Symposium, January 2007, Palm Springs, CA.

  • Nicholas J. Sanfilippo, M.D.

      Affiliations

    • Department of Radiation Oncology, New York University School of Medicine, New York, NY
    • Corresponding Author InformationReprint requests to: Nicholas J. Sanfilippo, M.D., New York University Clinical Cancer Center, Radiation Oncology Department, 160 East 34th Street, LL1, New York, NY 10016. Tel: (212) 731-5003; Fax: (212) 731-5517
    • ,
  • James Mitchell, M.D.

      Affiliations

    • Department of Radiation Oncology, New York University School of Medicine, New York, NY
    • ,
  • David Grew, M.P.H., M.D.

      Affiliations

    • Tulane School of Medicine, New Orleans, LA
    • ,
  • Mark DeLacure, M.D.

      Affiliations

    • Head and Neck Service, Department of Otolaryngology, New York University School of Medicine, New York, NY

Received 29 May 2009 ,Revised 11 June 2009 ,Accepted 18 June 2009.

References 

  1. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143–1153
  2. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–432
  3. Gichangi P, Bwayo J, Estambale B, et al. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006;100:405–411
  4. Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities. Int J Radiat Oncol Biol Phys. 2006;66:206–211
  5. Place RJ, Gregorcyk SG, Huber PJ, et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum. 2001;44:506–512
  6. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys. 2000;47:1–12
  7. Le Bourgeois JP, Frikha H, Piedbois P, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol. 1994;30:263–266
  8. Kao GD, Devine P, Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: Acute response to radiation therapy. Arch Otolaryngol Head Neck Surg. 1999;125:873–876
  9. Gichangi P, Bwayo J, Estambale B, et al. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006;100:405–411
  10. Oehler-Janne ZC, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: A multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol. 2008;26:2550–2557
  11. Demopoulos BP, Vamvakas E, Ehrlich JE, et al. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med. 2003;127:589–592
  12. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. J Am Med Assoc. 2001;285:1736–1745
  13. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS. 1999;13:839–843
  14. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843–850
  15. Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution. J Clin Oncol. 2006;24:1064–1071
  16. Gibson MK, Forastiere AA. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol. 2006;7:565–574
  17. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
  18. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol. 2003;66:253–262
  19. Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities. Int J Radiat Oncol Biol Phys. 2006;66:206–211
  20. Hoffman R, Welton ML, Klencke B, et al. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999;44:127–131
  21. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum. 2001;44:1496–1502
  22. Chadha M, Rosenblatt EA, Malamud S, et al. Squamous-cell carcinoma of the anus in HIV-positive patient. Dis Colon Rectum. 1994;37:861–865
  23. Peddada AV, Smith DE, Rao AR, et al. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 1997;37:1101–1105
  24. Blazy A, Hennequin C, Gornet J, et al. Anal carcinomas in HIV-positive patients: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2005;48:1176–1181
  25. List MA, Rutherford JL, Stracks J, et al. Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients. Head Neck. 2004;2:163–1670
  26. Rosenthal DI. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol. 2007;5(9 Suppl 4):23–31
  27. Groome PA, O'Sullivan B, Mackillop WJ, et al. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys. 2006;64:1002–1012

 Note—An online CME test for this article can be taken at http://asro.astro.org under Continuing Education.

 Conflict of interest: none.

PII: S0360-3016(09)02935-6

doi: 10.1016/j.ijrobp.2009.06.087

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 5 , Pages 1375-1379 , 1 August 2010

Article Tools